Clinical-stage biotechnology company developing therapies for liver and viral diseases, including chronic hepatitis B, MASH, and coronaviruses
Clinical-stage biotechnology company developing therapies for liver and viral diseases, including chronic hepatitis B, MASH, and coronaviruses. Its pipeline includes an oral small-molecule capsid assembly modulator and an antisense oligonucleotide for chronic HBV.